CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells.

Arroyo Hornero R., Georgiadis C., Hua P., Trzupek D., He L-Z., Qasim W., Todd JA., Ferreira RC., Wood KJ., Issa F., Hester J.

Regulatory T cells (Tregs) are critical mediators of immune homeostasis. The co-stimulatory molecule CD27 is a marker of highly suppressive Tregs, although the role of the CD27-CD70 receptor-ligand interaction in Tregs is not clear. Here we show that after prolonged in vitro stimulation, a significant proportion of human Tregs gain stable CD70 expression while losing CD27. The expression of CD70 in expanded Tregs is associated with a profound loss of regulatory function and an unusual ability to provide CD70-directed co-stimulation to TCR-activated conventional T cells. Genetic deletion of CD70 or its blockade prevents Tregs from delivering this co-stimulatory signal, thus maintaining their regulatory activity. High resolution targeted single-cell RNA sequencing of human peripheral blood confirms the presence of CD27-CD70+ Treg cells. These findings have important implications for Treg-based clinical studies where cells are expanded over extended periods in order to achieve sufficient treatment doses.

DOI

10.1038/s42003-020-1097-8

Type

Journal article

Journal

Commun Biol

Publication Date

14/07/2020

Volume

3

Keywords

Animals, CD27 Ligand, CRISPR-Associated Protein 9, CRISPR-Cas Systems, Female, Flow Cytometry, Forkhead Transcription Factors, Gene Editing, Gene Knockout Techniques, Humans, Mice, Inbred BALB C, Sequence Analysis, RNA, T-Lymphocytes, Regulatory, Transcriptome, Tumor Necrosis Factor Receptor Superfamily, Member 7

Permalink Original publication